{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T12:21:33Z","timestamp":1699964493363},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"S3","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1007\/s00115-007-2366-1","type":"journal-article","created":{"date-parts":[[2007,10,11]],"date-time":"2007-10-11T16:57:58Z","timestamp":1192121878000},"page":"551-564","source":"Crossref","is-referenced-by-count":2,"title":["Pharmakotherapie bei therapieresistenter Depression"],"prefix":"10.1007","volume":"78","author":[{"given":"A.","family":"Tadi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Lieb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,10,13]]},"reference":[{"key":"2366_CR1","first-page":"Sonderheft","volume":"33","author":"Akd\u00c4","year":"2006","unstructured":"Akd\u00c4 (Arzneimittelkommission der deutschen \u00c4rzteschaft) (2006) Empfehlungen zur Therapie der Depression, 2. Aufl. Arzneiverordnung in der Praxis 33: Sonderheft 1","journal-title":"Arzneiverordnung in der Praxis"},{"key":"2366_CR2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0165-0327(99)00092-0","volume":"58","author":"Anderson","year":"2000","unstructured":"Anderson IM (2000) Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord 58: 19\u201336","journal-title":"J Affect Disord"},{"key":"2366_CR3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/15622970701227829","volume":"8","author":"Bauer","year":"2007","unstructured":"Bauer M, Bschor T, Pfennig A et al., WFSBP Task Force on Unipolar Depressvie Disorders (2007) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care. World J Biol Psychiatry 8: 67\u2013104","journal-title":"World J Biol Psychiatry"},{"key":"2366_CR4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1055\/s-2004-832687","volume":"37","author":"Baumann","year":"2004","unstructured":"Baumann P, Hiemke C, Ulrich S et al.; Arbeitsgemeinschaft fur Neuropsychopharmakologie und -pharmakopsychiatrie (2004) The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry. Pharmacopsychiatry 37: 243\u2013265","journal-title":"Pharmacopsychiatry"},{"key":"2366_CR5","unstructured":"Benkert O, Hippius H (2006) Kompendium der Psychiatrischen Pharmakotherapie. Springer, Berlin Heidelberg New York"},{"key":"2366_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2005.08.012","volume":"89","author":"Dodd","year":"2005","unstructured":"Dodd S, Horgan D, Malhi GS et al. (2005) To combine or not to combine? A literature review of antidepressant combination therapy. J Affect Disord 89: 1\u201311","journal-title":"J Affect Disord"},{"key":"2366_CR7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2165\/00023210-200519040-00001","volume":"19","author":"Herpfer","year":"2005","unstructured":"Herpfer I, Lieb K (2005) Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential. CNS Drugs 19: 275\u2013293","journal-title":"CNS Drugs"},{"key":"2366_CR8","first-page":"28","volume":"1","author":"Leitner","year":"2004","unstructured":"Leitner I, Bailer U, Letmaier M et al. (2004) Behandlungsm\u00f6glichkeiten der therapieresistenten Depression. J Neurol Neurochir Psychiatr 1: 28\u201338","journal-title":"J Neurol Neurochir Psychiatr"},{"key":"2366_CR9","unstructured":"Lieb K (2005) Affektive St\u00f6rungen. In: Brunnhuber S, Frauenknecht S, Lieb K (Hrsg) Intensivkurs Psychiatrie. Urban & Fischer Elsevier, M\u00fcnchen Jena"},{"key":"2366_CR10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.psc.2007.01.001","volume":"30","author":"Nierenberg","year":"2007","unstructured":"Nierenberg AA, Katz J, Fava M (2007) A critical overview of the pharmacologic management of treatment-resistent depression. Psychiatr Clin N Am 30: 13\u201329","journal-title":"Psychiatr Clin N Am"},{"key":"2366_CR11","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.4088\/JCP.v67n1203","volume":"67","author":"Ruhe","year":"2006","unstructured":"Ruhe HG, Huyser J, Swinkels JA et al. (2006) Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review. J Clin Psychiatry 67: 1836\u20131855","journal-title":"J Clin Psychiatry"},{"key":"2366_CR12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2710.2006.00763.x","volume":"31","author":"Shams","year":"2006","unstructured":"Shams ME, Arneth B, Hiemke C et al. (2006) CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine. J Clin Pharm Ther 31: 493\u2013502","journal-title":"J Clin Pharm Ther"},{"key":"2366_CR13","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4088\/JCP.v64n0410","volume":"64","author":"Szegedi","year":"2003","unstructured":"Szegedi A, M\u00fcller MJ, Anghelescu IG et al. (2003) Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression. J Clin Psychiatry 64: 413\u2013420","journal-title":"J Clin Psychiatry"},{"key":"2366_CR14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/ajmg.b.30462","volume":"144","author":"Tadic","year":"2007","unstructured":"Tadic A, M\u00fcller MJ, Rujescu D et al. (2007) The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression. Am J Med Genet B Neuropsychiatr Genet 144: 325\u2013331","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"2366_CR15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","volume":"163","author":"Trivedi","year":"2006","unstructured":"Trivedi MH, Rush AJ, Wisniewski SR et al.; STAR*D Study Team. (2006) Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 163: 28\u201340","journal-title":"Am J Psychiatry"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-007-2366-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-007-2366-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-007-2366-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T05:08:30Z","timestamp":1558588110000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-007-2366-1"}},"subtitle":["Neue Entwicklungen"],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":15,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["2366"],"URL":"https:\/\/doi.org\/10.1007\/s00115-007-2366-1","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}